Taiwan FDA registration d225c7720092edce7c8dd3b4f509067c
LIAISON XL HCG
TW: 禮雅尚人類絨毛膜促性腺激素檢驗試劑組
Taiwan·Risk Class 3·MD·DIASORIN ITALIA S.P.A.·Registered Jan 23, 2018 – Jan 23, 2028ActiveRegistration details
- Analysis ID
- d225c7720092edce7c8dd3b4f509067c
- License Form
- Ministry of Health Medical Device Import No. 030488
- Customs Code
- DHA05603048801
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- MEDRICH INSTRUMENT CO., LTD.
Product details
- Intended Use
- This product is used for the quantitative detection of human chorionic gonadotropins (hCG and ßhCG) in serum in vitro. This test must be performed on the LIAISON analyzer series.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1155 Human chorionic gonadotropin test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 23, 2018
- Expiry Date
- Jan 23, 2028
About this record
Access comprehensive regulatory information for LIAISON XL HCG in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number d225c7720092edce7c8dd3b4f509067c and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices